Henriette Ytting

Medicine & Life Sciences

1. Autoimmune Hepatitis 100%
2. Sclerosing Cholangitis 82%
3. Mannose-Binding Lectin 53%
4. Biliary Liver Cirrhosis 46%
5. Mannose-Binding Protein-Associated Serine Proteases 45%
6. Fibrosis 40%
7. Acute Liver Failure 32%
8. Inflammatory Bowel Diseases 31%
9. Liver Cirrhosis 27%
10. Colorectal Neoplasms 26%
11. Ursodeoxycholic Acid 24%
12. Mycophenolic Acid 23%
13. Liver Diseases 23%
14. Tacrolimus 21%
15. Serum 20%
16. Cohort Studies 19%
17. Therapeutics 18%
18. Type 1 Diabetes Mellitus 17%
19. microfibrillar protein 17%
20. Autoimmune Diseases 16%
21. ficolin 15%
22. vedolizumab 15%
23. Biomarkers 15%
24. Rifaximin 14%
25. Pulmonary Surfactant-Associated Protein D 14%
26. Exercise 14%
27. Magnetic Resonance Cholangiopancreatography 13%
28. Alcoholic Hepatitis 13%
29. Portal Hypertension 13%
30. Liver 13%
31. Liver Transplantation 13%
32. Pediatrics 13%
33. Vascular Endothelial Growth Factor Receptor-1 12%
34. Chemical and Drug Induced Liver Injury 12%
35. Hepatolenticular Degeneration 12%
36. Penicillamine 12%
37. Complement System Proteins 12%
38. Everolimus 12%
39. Coronavirus 12%
40. Hepatitis A 12%
41. Lectins 11%
42. Confidence Intervals 11%
43. Plasma Exchange 11%
44. Tumor Necrosis Factor Inhibitors 11%
45. Vascular Endothelial Growth Factor Receptor 11%
46. Salvage Therapy 11%
47. Denmark 11%
48. Alkaline Phosphatase 11%
49. Ascitic Fluid 11%
50. Mannose-Binding Lectin Complement Pathway 10%